BioXcel Therapeutics (BTAI) stock gains as company shifts focus from commercial support for FDA-approved drug, Igalmi to lead ...
Patients undergoing complex gastrointestinal malignancy surgeries experience various challenges such as immune system ...
Recently initiated SERENITY At-Home pivotal Phase 3 trial for agitation associated with bipolar disorders or schizophrenia ...
Research on using sedation to improve patient tolerance to noninvasive ventilation (NIV) after traumatic chest injuries is ...